Certificate of Analysis
HEMP QUALITY ASSURANCE TEST

Sample Name:

Sleep Sota Drops

Infused, Liquid Edible

Date Issued:

04/10/2025

Total THC 0.025 mg/mL
Total CBD 35.507 mg/mL
Sum Cannabinoids 71.055 mg/mL
Total Cannabinoids 71.055 mg/mL

Sample Information

Sample Details

Sample ID:250407N062

Batch Number:SD.CBDCBN.040225

Cultivator / Manufacturer

Show Details

Distributor / Tested For

Show Details

Share

Easily share a link to this results page with your friends, followers, or business partners.

Cannabinoid Analysis - Summary

Total THC: 0.025 mg/mL

Total CBD: 35.507 mg/mL

Sum of Cannabinoids: 71.055 mg/mL

Total Cannabinoids: 71.055 mg/mL

Density:1.0127 g/mL

Total THC/CBD is calculated using the following formulas to take into account the loss of a carboxyl group during the decarboxylation step:
Total THC = Δ9-THC + (THCa (0.877))
Total CBD = CBD + (CBDa (0.877))

Sum of Cannabinoids = Δ9-THC + THCa + CBD + CBDa + CBG + CBGa + THCV + THCVa + CBC + CBCa + CBDV + CBDVa + Δ8-THC + CBL + CBN

Total Cannabinoids = (Δ9-THC+0.877*THCa) + (CBD+0.877*CBDa) + (CBG+0.877*CBGa) + (THCV+0.877*THCVa) + (CBC+0.877*CBCa) + (CBDV+0.877*CBDVa) + Δ8-THC + CBL + CBN

Sum of Cannabinoids: The concentration of each individual cannabinoid added together as they are, without accounting for decarboxylation. This measurement is of particular importance for certain cannabis products that are not intended to be heated prior to application or consumption.

Total Cannabinoids: The concentration of each acidic cannabinoid, multiplied by 0.877 to account for the loss of molecular mass that happens as it is converted to a neutral cannabinoid when heated. Then this calculated concentration is added to the concentrations of the corresponding neutral cannabinoid already present. This corrected data is of particular importance to both producers and consumers of products intended to be heated prior to application or consumption.

View Complete Test Results:

Tested by high-performance liquid chromatography with diode-array detection (HPLC-DAD).

Method: QSP 1157 - Analysis of Cannabinoids by HPLC-DAD

Summary

Total THC: 0.025 mg/mL

9-THC+0.877*THCa)

Total CBD: 35.507 mg/mL

(CBD+0.877*CBDa)

Total Cannabinoids: 71.055 mg/mL

Total CBG: 0.007 mg/mL

Total CBG (CBG+0.877*CBGa)

Total THCV: ND

Total THCV (THCV+0.877*THCVa)

Total CBC: 0.052 mg/mL

Total CBC (CBC+0.877*CBCa)

Total CBDV: 0.130 mg/mL

Total CBDV (CBDV+0.877*CBDVa)

Learn more

The cannabis plant contains dozens of active compounds called cannabinoids. These compounds are the primary contributors to the psychoactive effects of cannabis.

Cannabinoid testing determines the potency of a sample to aid in dosage considerations.

Cannabinoid Test Results

04/10/2025

Result Views

Swipe left on table to see additional columns

Compound LOD/LOQ
(mg/mL)
Measurement
Uncertainty
(mg/mL)
Result
(mg/mL)
Result
(%)
Cannabidiol (CBD) 0.004 / 0.011 ±1.3244 35.507 3.5062
Cannabinol (CBN) 0.001 / 0.007 ±1.0141 35.334 3.4891
Cannabidivarin (CBDV) 0.002 / 0.012 ±0.0053 0.130 0.0128
Cannabichromene (CBC) 0.003 / 0.010 ±0.0017 0.052 0.0051
Δ9 Tetrahydrocannabinol (Δ9THC) 0.002 / 0.014 ±0.0014 0.025 0.0025
Cannabigerol (CBG) 0.002 / 0.006 ±0.0003 0.007 0.0007
Cannabicyclol (CBL) 0.003 / 0.010 N/A ND ND
Cannabichromenic Acid (CBCa) 0.001 / 0.015 N/A ND ND
Cannabidiolic Acid (CBDa) 0.001 / 0.026 N/A ND ND
Cannabigerolic Acid (CBGa) 0.002 / 0.007 N/A ND ND
Tetrahydrocannabivarin (THCV) 0.002 / 0.012 N/A ND ND
Tetrahydrocannabinolic Acid (THCa) 0.001 / 0.005 N/A ND ND
Cannabidivarinic Acid (CBDVa) 0.001 / 0.018 N/A ND ND
Tetrahydrocannabivarinic Acid (THCVa) 0.002 / 0.019 N/A ND ND
∆8 Tetrahydrocannabinol (Δ8THC) 0.01 / 0.02 N/A ND ND
SUM OF CANNABINOIDS 71.055 mg/mL 7.0164%
Density Test Result

1.0127 g/mL Tested 04/10/2025 Method: QSP 7870 - Sample Preparation

Learn more

The cannabis plant contains dozens of active compounds called cannabinoids. These compounds are the primary contributors to the psychoactive effects of cannabis.

Cannabinoid testing determines the potency of a sample to aid in dosage considerations.

Your current browser is unsupported. Please install latest version of Firefox, Chrome or IE to view this site.